{"abstract": "Merck spent $7 million in the second quarter to defend itself in the first of at least 900 pending cases in which plaintiffs claim that taking Fosamax caused jaw injuries.", "web_url": "https://www.nytimes.com/2009/09/03/business/03drug.html", "snippet": "Merck spent $7 million in the second quarter to defend itself in the first of at least 900 pending cases in which plaintiffs claim that taking Fosamax caused jaw injuries.", "lead_paragraph": "Drug executives, product liability lawyers and Wall Street analysts are closely watching a jury trial in New York over medical problems associated with Fosamax, a drug from Merck that has been taken by millions of women to offset the bone loss associated with menopause. ", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [], "headline": {"main": "High Stakes for Merck in Litigation on Fosamax", "kicker": null, "content_kicker": null, "print_headline": "High Stakes For Merck In Litigation On Fosamax", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "persons", "value": "Keenan, John F", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Merck & Company Inc", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Liability for Products", "rank": 4, "major": "N"}, {"name": "subject", "value": "Suits and Litigation", "rank": 5, "major": "N"}], "pub_date": "2009-09-03T01:56:35+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Natasha Singer", "person": [{"firstname": "Natasha", "middlename": null, "lastname": "Singer", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/a30d672a-d1ad-5a62-bfac-261707b4256d", "word_count": 1265, "uri": "nyt://article/a30d672a-d1ad-5a62-bfac-261707b4256d"}